Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lucid Diagnostics Inc. - Common Stock (NQ:LUCD)

1.270 +0.040 (+3.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Lucid Diagnostics Inc. - Common Stock

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
LUCID DIAGNOSTICS INC (NASDAQ:LUCD) Reports Q2 2025 Earnings In Line with Estimates, Narrower Loss Than Expected
Lucid Diagnostics (LUCD) Q2 2025 results: Revenue $1.16M, EPS -$0.10, beating estimates. Processed 2,756 EsoGuard tests, maintains $30M+ cash. Stock up 2.26% pre-market. 
Via Chartmill
LUCD Reports Results
Via The Motley Fool
Topics Intellectual Property
SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
A Glimpse of Lucid Diagnostics's Earnings Potential
 
Via Benzinga
Earnings Scheduled For November 13, 2024
 
Via Benzinga
A Glimpse of Lucid Diagnostics's Earnings Potential
 
Via Benzinga
Earnings Scheduled For August 13, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst
A Needham analyst predicts that Lucid Diagnostics (NASDAQ: LUCD) will see a surge in testing volumes with expected Medicare reimbursement approval. 
Via Benzinga
Earnings Scheduled For May 14, 2025
 
Via Benzinga
Top stock movements in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Top movers analysis in the middle of the day on 2025-04-10: top gainers and losers in today's session.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
These stocks are gapping in today's session
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
Which stocks are moving before the opening bell on Thursday?
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway
On Stocktwits, sentiment for the stock climbed higher within the 'extremely bullish' zone late Wednesday, while message volume rose by more than 18%. 
Via Stocktwits
Topics Earnings
Curious about the stocks that are showing activity after the closing bell on Wednesday?
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Earnings Scheduled For March 24, 2025
 
Via Benzinga
Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q2 2024
LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
3 Hypergrowth Stocks That Speculators Should Keep Tabs On
While a high-risk proposition, these hypergrowth stocks can potentially bring enormous returns in a short period of time. 
Via InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024
Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments. 
Via InvestorPlace
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024
LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.